-- Acorda, Clearwire, CSX, MGM, Myriad Genetics, St. Joe: U.S. Equity Movers
-- B y   W h i t n e y   K i s l i n g
-- 2010-10-13T20:30:14Z
-- http://www.bloomberg.com/news/2010-10-13/big-lots-office-depot-sprint-williams-u-s-equity-movers.html
Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are as of 4 p.m.  Acorda Therapeutics Inc.  (ACOR US) declined 5.8 percent,
the most since June 4, to $28.40. The biotechnology company may
see sales of its Ampyra multiple-sclerosis drug hurt by
insurance co-pay costs, analyst  Elemer Piros  at Rodman & Renshaw
Inc. said in a note. The analyst holds a “cautious” view on
the drug’s sales and reiterated an “underperform” rating on the
stock.  Adtran Inc.  (ADTN US) declined 6.1 percent, the most since
June 4, to $33.37. The maker of high-speed digital transmission
products declared a quarterly dividend of 9 cents a share,
compared with the Bloomberg forecast of 10 cents.  Clearwire Corp.  (CLWR US) rose 6.8 percent, the most since
March 8, to $7.21. The high-speed wireless carrier is seeking to
raise $2.5 billion to $5 billion in a wireless-spectrum auction
that has attracted telephone and cable companies, said people
with direct knowledge of the sale.  CSX Corp.  (CSX US) gained 4.2 percent, the most since June
10, to $59.66. The second-largest publicly traded U.S. railroad
reported third-quarter profit excluding some items of $1.08 a
share, beating the average analyst estimate of $1.04. The
railroad is “actively hiring” workers as the economy slowly
improves and may add as many as 3,000 next year, Chief Executive
Officer  Michael Ward  told CNBC.  MGM Resorts International  (MGM US) declined 11 percent, the
most since Oct. 27, to $12.10. The biggest casino operator on
the Las Vegas Strip plans to raise more than $500 million by
selling stock, and said its founder and biggest shareholder will
reduce his stake.  Myriad Genetics Inc.  (MYGN US) rose 6.9 percent to $19.94,
the highest price since May 4. The maker of a test for detecting
inherited breast cancer was raised to “outperform” from
“sector perform” at RBC Capital Markets Corp., which said the
company may be a takeover target for Roche Holding AG (ROG VX),
AstraZeneca Plc (AZN LN) or Sanofi-Aventis SA (SAN FP).  St. Joe Co.  (JOE US) fell 9.7 percent, the most since April
30, to $22.16.  David Einhorn , who profited from bets against
Lehman Brothers Holdings Inc. in 2008, said the Florida real-
estate firm must take “substantial” asset-impairment charges and
that further building will drive the stock price to zero.  Williams Cos.  (WMB US) rose 9.8 percent, the most since
November 2008, to $21.53. The U.S. natural-gas pipeline operator
said that Chairman and Chief Executive Officer  Steve Malcolm 
will retire at the end of this year.  Alan Armstrong  will succeed
Malcolm as Williams CEO, while  Frank MacInnis  will be chairman.  To contact the reporter on this story:
 Whitney Kisling  in New York at 
 wkisling@bloomberg.net .  To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net . 